Research on Group B Streptococcus is ongoing, with potential developments including a vaccine that could save thousands of lives and a rapid test for newborns. The infection poses a risk to newborns and has been linked to various neurodevelopmental outcomes. Global efforts are also focused on understanding and addressing antimicrobial resistance trends and the burden of Group B Streptococcus infection during pregnancy and infancy.